Doctor profile · Federal record
Dr. Aashini Master, D.O
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Beverly Hills, CA
- NPI 1154557387
- Accepts Medicare
- MIPS 84.9 / 100 · 2023
- 19 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
120 S Spalding Dr Ste 401
Beverly Hills, CA 902121842
(310) 205-0771
fax (310) 205-0801 - Additional location
-
2020 Santa Monica Blvd Ste 580
Santa Monica, CA 904042000
(310) 829-5471
fax (310) 829-6192 - Mailing address
-
5767 W Century Blvd Ste 400
Los Angeles, CA 900455631
Credentials & registration
- NPI registered
- June 2009 — 17 yrs on file
- Profile last updated
- January 16, 2020
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- California #20A10821 · California #20A18021
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1154557387. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,839
Distinct HCPCS
10
Medicare allowed
$181,988
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,500 | 11 | $23 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 530 | 11 | $8 | |
J9394 |
Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg | 520 | 13 | $21 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 478 | 21 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 370 | 12 | $1 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 368 | 17 | $0 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 266 | 134 | $141 | |
J7050 |
Infusion, normal saline solution, 250 cc | 256 | 64 | $1 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 218 | 98 | $8 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 136 | 46 | $155 |
In context: peer comparison
Among 7 peers in Beverly Hills Hematology & Oncology Physician, average services per provider: 704. This provider delivers 8.3× the peer median.Open Payments
Industry payments received
All-time total
$13,293
Transactions
17
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gilead Sciences, INC. | 11 | $11,140.03 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $1,942.50 | |
| Novartis Pharmaceuticals Corporation | 2 | $137.96 | |
| BeiGene USA, INC. | 3 | $72.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
390
Patients
84
Total drug cost
$740,336
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 198 | 64 | $6,172 |
| Letrozole | Generic | 60 | 20 | $1,974 |
| Tamoxifen Citrate | Generic | 35 | 0 | $1,026 |
| Verzenio (Abemaciclib) | Brand | 31 | 0 | $498,304 |
| Zarxio (Filgrastim-Sndz) | Brand | 19 | 0 | $39,789 |
| Alendronate Sodium | Generic | 12 | 0 | $166 |
| Hydroxyurea | Generic | 12 | 0 | $440 |
| Xtandi (Enzalutamide) | Brand | 12 | 0 | $178,183 |
| Xarelto (Rivaroxaban) | Brand | 11 | 0 | $14,282 |
Hospital affiliations
Frequently asked questions
What is Dr. Aashini Master's medical specialty?
Dr. Aashini Master practices Hematology & Oncology Physician in Beverly Hills, CA.
Where does Dr. Aashini Master practice?
Dr. Aashini Master practices at 120 S Spalding Dr Ste 401, Beverly Hills, CA 902121842. Office phone: 3102050771.
What is Dr. Aashini Master's NPI?
Dr. Aashini Master's National Provider Identifier (NPI) is 1154557387, issued by NPPES.
Does Dr. Aashini Master accept Medicare assignment?
Yes. Dr. Aashini Master accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Aashini Master commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS Q5106); Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg (HCPCS J9394). Source: CMS Medicare Physician & Other Practitioners file.